Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Coleman Website

C. Norman Coleman, M.D.

Selected Publications

1)  Simone CB, John-Aryankalayil M, Palayoor ST, Makinde AY, Cerna D, Falduto MT, Magnuson SR, Coleman CN.
mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 Status.
Transl Oncol. 6: 573-85, 2013.
2)  Makinde AY, John-Aryankalayil M, Palayoor ST, Cerna D, Coleman CN.
Radiation survivors: understanding and exploiting the phenotype following fractionated radiation therapy.
Mol. Cancer Res. 11: 5-12, 2013.
3)  John-Aryankalayil M, Palayoor ST, Makinde AY, Cerna D, Simone CB, Falduto MT, Magnuson SR, Coleman CN.
Fractionated Radiation Alters Oncomir and Tumor Suppressor miRNAs in Human Prostate Cancer Cells.
Radiat Res. 178: 105-17, 2012.
4)  Palayoor ST, J-Aryankalayil M, Makinde AY, Cerna D, Falduto MT, Magnuson SR, Coleman CN.
Gene expression profile of coronary artery cells treated with nonsteroidal anti-inflammatory drugs reveals off-target effects.
J. Cardiovasc. Pharmacol. 59: 487-99, 2012.
5)  Coleman CN.
Fukushima and the future of radiation research.
Radiat. Res. 179: 1-8, 2013.
6)  Prasanna A, Ahmed MM, Mohiuddin M, Coleman CN.
Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy.
J Thorac Dis. 6: 287-302, 2014.
7)  Yoo SS, Jorgensen TJ, Kennedy AR, Boice Jr JD, Shapiro A, Hu TC, Moyer BR, Grace MB, Kelloff GJ, Fenech M, Prasanna PG, Coleman CN.
Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development.
J Radiol Prot. 34: R25-R52, 2014.
8)  Sullivan JM, Prasanna PG, Grace MB, Wathen LK, Wallace RL, Koerner JF, Coleman CN.
Assessment of biodosimetry methods for a mass-casualty radiological incident: medical response and management considerations.
Health Phys. 105: 540-54, 2013.
9)  Liu FF, Okunieff P, Bernhard EJ, Stone HB, Yoo S, Coleman CN, Vikram B, Brown M, Buatti J, Guha C.
Lessons learned from radiation oncology clinical trials.
Clin. Cancer Res. 19: 6089-100, 2013.
10)  Lawrence YR, Vikram B, Dignam JJ, Chakravarti A, Machtay M, Freidlin B, Takebe N, Curran WJ, Bentzen SM, Okunieff P, Coleman CN, Dicker AP.
NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.
J. Natl. Cancer Inst. 105: 11-24, 2013.
Click Here to View Expanded Bibliography.

This page was last updated on 6/13/2014.